{"id":184,"date":"2026-07-13T16:53:31","date_gmt":"2026-07-13T16:53:31","guid":{"rendered":"https:\/\/dcenbd.com\/?post_type=product&#038;p=184"},"modified":"2026-07-13T16:53:31","modified_gmt":"2026-07-13T16:53:31","slug":"luciale-150-mg-alectinib","status":"publish","type":"product","link":"https:\/\/dcenbd.com\/index.php\/product\/luciale-150-mg-alectinib\/","title":{"rendered":"LuciAle 150 Mg (Alectinib)"},"content":{"rendered":"<h2>Description:<\/h2>\n<p><strong>Overview-<\/strong><br \/>\nLuciAle 150mg is an oral capsule containing Alectinib 150 mg (as Alectinib hydrochloride 161.33 mg), manufactured by Lucius Pharmaceutical Co., Ltd., Vientiane, Laos (WHO-GMP certified). It is a highly selective, second-generation ALK (anaplastic lymphoma kinase) inhibitor used to treat ALK-positive non-small cell lung cancer (NSCLC), including disease that has spread to the brain.<br \/>\nLuciAle contains the same active ingredient as\u00a0<a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/208434s012lbl.pdf\" target=\"_blank\" rel=\"noopener\">Alecensa\u00ae (Genentech\/Roche)<\/a>, first approved by the US FDA in 2015.<\/p>\n<p><strong>How LuciAle 150mg Works:<\/strong><br \/>\nAlectinib selectively blocks the ALK tyrosine kinase and the RET receptor. In ALK-positive NSCLC, an abnormal ALK gene drives uncontrolled cancer cell growth. By inhibiting ALK signaling, LuciAle slows tumor progression and triggers cancer cell death. A key advantage is its ability to cross the blood-brain barrier, making it effective against brain (CNS) metastases \u2014 a common site of spread in ALK-positive lung cancer.\u00a0<a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=42c49deb-713b-427a-9670-08af08adcffb\" target=\"_blank\" rel=\"noopener\">See the full alectinib drug profile on NIH DailyMed<\/a>.<\/p>\n<p><strong>Uses:<\/strong><br \/>\nLuciAle 150mg is prescribed for:<\/p>\n<p>First-line treatment of adult patients with ALK-positive metastatic NSCLC (confirmed by an FDA-approved test)<br \/>\nAdjuvant treatment following complete tumor resection in ALK-positive NSCLC (tumors \u22654 cm or node-positive)<br \/>\nALK-positive NSCLC that has progressed on or is intolerant to crizotinib<br \/>\nNSCLC with brain metastases, due to strong central nervous system penetration<\/p>\n<p>A confirmed ALK-positive diagnosis is required before treatment begins.<\/p>\n<p><strong>Dosage:<\/strong><br \/>\nDetailInformationRecommended dose600 mg (four 150 mg capsules) orally twice daily \u2014 1,200 mg\/day totalAdministrationTake with food; swallow capsules wholeImportantDo not open or dissolve the capsulesSevere hepatic impairmentReduced to 450 mg twice dailyMissed dose \/ vomitingSkip it; take the next dose at the scheduled time \u2014 do not double upDurationContinue until disease progression or unacceptable toxicity (adjuvant: up to 2 years)<br \/>\nAlways follow your oncologist\u2019s prescription. Full prescribing details are in the\u00a0<a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/208434s012lbl.pdf\" target=\"_blank\" rel=\"noopener\">official FDA label for Alecensa (alectinib)<\/a>. Storage: keep in a dry place at 20\u201325\u00b0C, away from light and out of reach of children.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Product Specifications:<\/strong><\/p>\n<p>Active Ingredient: Alectinib 150 mg (as Alectinib HCl 161.33 mg)<br \/>\nDrug Class: Selective ALK \/ RET Tyrosine Kinase Inhibitor (second-generation)<br \/>\nManufacturer: Lucius Pharmaceutical Co., Ltd., Vientiane, Laos \u2014 WHO-GMP certified<br \/>\nReference Brand: Alecensa\u00ae (Genentech \/ Roche)<br \/>\nForm: Hard oral capsule<\/p>\n<p><strong>Side Effects:<\/strong><br \/>\nCommon: fatigue, constipation, swelling (edema), muscle pain (myalgia), rash, cough, anemia.<br \/>\nCommon laboratory changes: raised liver enzymes (AST\/ALT), increased bilirubin, increased creatine phosphokinase (CPK), high blood sugar, low calcium.<br \/>\nSerious (seek medical help immediately): liver toxicity, lung inflammation (interstitial lung disease\/pneumonitis), slow heartbeat (bradycardia), severe muscle pain with CPK elevation, kidney problems, hemolytic anemia.<br \/>\nLiver function should be monitored every 2 weeks for the first 3 months, then monthly. Avoid sun exposure and use sunscreen, as alectinib can cause photosensitivity. Not for use during pregnancy \u2014 see FAQ.<\/p>\n<p><strong>FAQ:<\/strong><br \/>\nWhat is LuciAle 150mg used for?<br \/>\nLuciAle 150mg is used to treat ALK-positive non-small cell lung cancer (NSCLC), including as first-line therapy, after surgery (adjuvant), and for cancer that has spread to the brain.<br \/>\nIs LuciAle the same as Alecensa?<br \/>\nYes. Both contain Alectinib as the active ingredient. LuciAle is the Lucius Pharmaceutical (Laos) version of Alecensa\u00ae.<br \/>\nHow many capsules of LuciAle 150mg do I take?<br \/>\nThe recommended dose is 600 mg twice daily \u2014 that is four 150 mg capsules in the morning and four in the evening (eight capsules per day), taken with food.<br \/>\nWhy must LuciAle be taken with food?<br \/>\nFood significantly increases the absorption of alectinib (up to 3-fold), improving effectiveness and reducing stomach-related side effects.<br \/>\nDoes LuciAle work for brain metastases?<br \/>\nYes. Alectinib crosses the blood-brain barrier and is effective against central nervous system (brain) metastases, which are common in ALK-positive NSCLC.<br \/>\nDo I need a test before starting?<br \/>\nYes. A confirmed ALK-positive result via an FDA-approved test is required before treatment.<br \/>\nCan the dose be lowered for side effects?<br \/>\nYes. The dose can be reduced stepwise (600 mg \u2192 450 mg \u2192 300 mg twice daily). Treatment is stopped if the 300 mg twice-daily dose is not tolerated. Do not adjust the dose yourself.<br \/>\nIs it safe during pregnancy?<br \/>\nNo. Alectinib can harm an unborn baby. Women should use effective contraception during treatment and for 5 weeks after the last dose. Men with female partners should use contraception during and for 3 months after. Do not breastfeed during treatment and for 1 week after the last dose.<br \/>\nHow should it be stored?<br \/>\nIn a dry place at 20\u201325\u00b0C, away from light, and out of reach of children.<\/p>\n","protected":false},"excerpt":{"rendered":"<p><strong>LuciAle<\/strong> 150mg is an oral capsule containing Alectinib 150 mg (as Alectinib hydrochloride 161.33 mg), manufactured by Lucius Pharmaceutical Co., Ltd., Vientiane, Laos (WHO-GMP certified). It is a highly selective, second-generation ALK (anaplastic lymphoma kinase) inhibitor used to treat ALK-positive non-small cell lung cancer (NSCLC), including disease that has spread to the brain.<\/p>\n","protected":false},"featured_media":185,"comment_status":"open","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[35],"product_cat":[19],"product_tag":[],"class_list":["post-184","product","type-product","status-publish","has-post-thumbnail","product_brand-dcenbd-export-all-kind-of-medicine-from-lucius-pharmaceuticals","product_cat-lung-cancer","desktop-align-left","tablet-align-left","mobile-align-left","first","instock","shipping-taxable","product-type-simple"],"_links":{"self":[{"href":"https:\/\/dcenbd.com\/index.php\/wp-json\/wp\/v2\/product\/184","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dcenbd.com\/index.php\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/dcenbd.com\/index.php\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/dcenbd.com\/index.php\/wp-json\/wp\/v2\/comments?post=184"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dcenbd.com\/index.php\/wp-json\/wp\/v2\/media\/185"}],"wp:attachment":[{"href":"https:\/\/dcenbd.com\/index.php\/wp-json\/wp\/v2\/media?parent=184"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/dcenbd.com\/index.php\/wp-json\/wp\/v2\/product_brand?post=184"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/dcenbd.com\/index.php\/wp-json\/wp\/v2\/product_cat?post=184"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/dcenbd.com\/index.php\/wp-json\/wp\/v2\/product_tag?post=184"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}